The antioxidant and radical scavenging properties of Ginkgo flavonoids and terpenoids, as well as the potent platelet activating factor inhibition of ginkgolides, are believed to be responsible for the decreased platelet aggregation and enhanced blood circulation [235]
This combination is especially important for AOD-9604 users because the compound does not stimulate growth hormone, IGF-1, or any anabolic pathway
It helps in identifying the presence and the overgrowth type
Evidence-based recommendations are critical to ensure the safe and efficient use of these medications in the treatment of obesity as their use continues to increase
It is not intended for human or animal consumption, clinical use, diagnostic use, therapeutic use, cosmetic use, or as a food or supplement
Am J Physiol Endocrinol Metab (2012) 302:E7786